Yu Xia

3.7k total citations
119 papers, 2.4k citations indexed

About

Yu Xia is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yu Xia has authored 119 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 41 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yu Xia's work include Cancer Immunotherapy and Biomarkers (26 papers), Ferroptosis and cancer prognosis (11 papers) and Cancer-related molecular mechanisms research (9 papers). Yu Xia is often cited by papers focused on Cancer Immunotherapy and Biomarkers (26 papers), Ferroptosis and cancer prognosis (11 papers) and Cancer-related molecular mechanisms research (9 papers). Yu Xia collaborates with scholars based in China, United States and Australia. Yu Xia's co-authors include Gordon D. Ross, Jun Yan, Václav Větvička, Margareta Hanikýřová, Tanya N. Mayadas, Tanya N. Mayadas, Jana Větvičková, G D Ross, V Vetvicka and Malcolm W. Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yu Xia

114 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Xia China 22 712 698 478 334 274 119 2.4k
Xiaofeng Lu China 32 1.4k 2.0× 537 0.8× 430 0.9× 272 0.8× 457 1.7× 165 3.3k
Fei Huang China 22 765 1.1× 908 1.3× 296 0.6× 105 0.3× 351 1.3× 60 2.2k
Lei Shi China 32 1.1k 1.6× 1.4k 2.1× 196 0.4× 414 1.2× 435 1.6× 122 4.0k
Changjun Wang China 37 1.3k 1.8× 552 0.8× 777 1.6× 382 1.1× 606 2.2× 207 4.0k
Xing‐Hua Gao China 29 586 0.8× 532 0.8× 257 0.5× 115 0.3× 134 0.5× 197 3.1k
Hong‐Duo Chen China 30 714 1.0× 506 0.7× 222 0.5× 123 0.4× 158 0.6× 204 3.3k
Shoichi Suzuki Japan 25 733 1.0× 849 1.2× 215 0.4× 411 1.2× 118 0.4× 56 2.4k
Hyung‐Joo Kwon South Korea 29 1.3k 1.8× 986 1.4× 457 1.0× 110 0.3× 350 1.3× 145 2.8k
Gerhard Faller Germany 33 979 1.4× 1.1k 1.5× 458 1.0× 196 0.6× 242 0.9× 78 3.4k
Dhafer Laouini Tunisia 23 790 1.1× 1.3k 1.9× 279 0.6× 197 0.6× 327 1.2× 68 3.2k

Countries citing papers authored by Yu Xia

Since Specialization
Citations

This map shows the geographic impact of Yu Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xia more than expected).

Fields of papers citing papers by Yu Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xia. The network helps show where Yu Xia may publish in the future.

Co-authorship network of co-authors of Yu Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Xia. A scholar is included among the top collaborators of Yu Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Xia. Yu Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Minghua, et al.. (2026). DNA demethylation induced by self-DNA activates pattern-triggered immunity in postharvest citrus. Journal of Experimental Botany. 1 indexed citations
2.
Li, Xin, Wen Pan, Jun Jiang, et al.. (2025). Niraparib restricts intraperitoneal metastases of ovarian cancer by eliciting CD36-dependent ferroptosis. Redox Biology. 80. 103528–103528. 3 indexed citations
3.
Qi, Liang, Yu Xia, Jianmei Che, et al.. (2025). Detection of water adulteration levels in milk using near-infrared spectroscopy combined with chemometrics. Journal of Dairy Science. 108(7). 6852–6866. 4 indexed citations
4.
Zhang, Qiqi, et al.. (2025). Investigating casual association among gut microbiome and esophageal cancer: A Mendelian randomization study. Medicine. 104(8). e41563–e41563. 1 indexed citations
5.
Rao, Shanshan, Pu Huang, Yiyu Qian, Yu Xia, & Hongfeng Zhang. (2024). Colonic epithelial cell-specific TFEB activation: a key mechanism promoting anti-bacterial defense in response to Salmonella infection. Frontiers in Microbiology. 15. 1369471–1369471.
7.
Xia, Yu, et al.. (2024). Examining the link between gut microbiota and periodontitis in East Asians using Mendelian randomization. Health Science Reports. 7(10). e70103–e70103. 1 indexed citations
9.
Zhang, Yi, Yuzhi Wang, Jianlin Chen, Yu Xia, & Yi Huang. (2023). A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma. Frontiers in Immunology. 14. 8 indexed citations
10.
Li, Huayi, et al.. (2023). Semaphorin 4C accelerates disease progression and enables disease detection in breast cancer. SHILAP Revista de lepidopterología. 4. 6–6. 1 indexed citations
12.
Jin, Ping, Yu Xia, Huayi Li, et al.. (2023). Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts. Molecular Cancer Therapeutics. 22(4). 447–458. 9 indexed citations
13.
Wang, Siyuan, et al.. (2023). Suppression of GCH1 Sensitizes Ovarian Cancer and Breast Cancer to PARP Inhibitor. Journal of Oncology. 2023. 1–16. 3 indexed citations
14.
Chen, Zhiyu, Fang Li, Lei Fu, et al.. (2023). Role of inflammatory lipid and fatty acid metabolic abnormalities induced by plastic additives exposure in childhood asthma. Journal of Environmental Sciences. 137. 172–180. 8 indexed citations
16.
Xia, Yu, Yi Zhang, Liangming Zhang, et al.. (2022). Combination of serum CST4 and DR-70 contributes to early diagnosis of colorectal cancer. Clinica Chimica Acta. 531. 318–324. 12 indexed citations
17.
Xia, Yu, et al.. (2020). miRNA‐Based Feature Classifier Is Associated with Tumor Mutational Burden in Head and Neck Squamous Cell Carcinoma. BioMed Research International. 2020(1). 1686480–1686480. 8 indexed citations
18.
Markman, Ben, Ben Tran, Hui Gan, et al.. (2019). A Phase 1 study of AK104, a tetrameric bispecific antibody that targets PD-1 and CTLA-4 in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 7. 3 indexed citations
19.
Xia, Yu, et al.. (2016). Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Xia, Yu, Qian Liang, Huijuan He, et al.. (2009). Promotive Effect of Sulfatase 2 Gene in vivo Expression during mouse bone marrow depression and regeneration induced by Chemotherapy. Zhongguo shengwu gongcheng zazhi. 28(11). 1–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026